G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,634,988 | +2554.4% | 717,100 | +3450.9% | 0.04% | +1850.0% |
| Q4 2023 | $61,595 | -12.6% | 20,195 | -23.2% | 0.00% | +100.0% |
| Q1 2023 | $70,484 | -14.4% | 26,300 | +73.5% | 0.00% | -50.0% |
| Q4 2022 | $82,324 | -92.4% | 15,161 | -56.8% | 0.00% | -98.0% |
| Q2 2019 | $1,077,000 | – | 35,111 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $16,445,000 | 3.96% |
| Burrage Capital Management LLC | 228,597 | $2,640,000 | 2.08% |
| CHI Advisors LLC | 84,000 | $970,000 | 0.34% |
| Birchview Capital, LP | 80,000 | $924,000 | 0.31% |
| Jackson Creek Investment Advisors LLC | 47,294 | $546,000 | 0.25% |
| Rhenman & Partners Asset Management AB | 190,000 | $2,195,000 | 0.20% |
| AIGEN INVESTMENT MANAGEMENT, LP | 90,985 | $1,051,000 | 0.13% |
| Bellevue Group AG | 721,925 | $8,338,000 | 0.12% |
| PDT Partners, LLC | 139,924 | $1,616,000 | 0.11% |
| Virtus ETF Advisers LLC | 16,713 | $193,000 | 0.10% |